Helle Pappot

4.3k total citations
155 papers, 2.3k citations indexed

About

Helle Pappot is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Helle Pappot has authored 155 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Oncology, 48 papers in Surgery and 35 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Helle Pappot's work include Cancer survivorship and care (44 papers), Bladder and Urothelial Cancer Treatments (36 papers) and Childhood Cancer Survivors' Quality of Life (26 papers). Helle Pappot is often cited by papers focused on Cancer survivorship and care (44 papers), Bladder and Urothelial Cancer Treatments (36 papers) and Childhood Cancer Survivors' Quality of Life (26 papers). Helle Pappot collaborates with scholars based in Denmark, United States and Sweden. Helle Pappot's co-authors include Keld Danø, Birgit Guldhammer Skov, Gunilla Høyer‐Hansen, J Grøndahl-Hansen, Christoffer Johansen, Ib Jarle Christensen, Nils Brünner, Gry Assam Taarnhøj, Ebbe Rønne and Barbara Malene Fischer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Helle Pappot

149 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helle Pappot Denmark 25 1.2k 683 467 382 369 155 2.3k
Alan P. Lyss United States 27 1.2k 1.1× 327 0.5× 879 1.9× 323 0.8× 374 1.0× 66 2.7k
G Lindmark Sweden 36 2.2k 1.8× 571 0.8× 446 1.0× 1.2k 3.1× 680 1.8× 113 3.7k
Tom Børge Johannesen Norway 26 2.1k 1.8× 457 0.7× 1.0k 2.2× 671 1.8× 673 1.8× 89 3.8k
N Stuart United Kingdom 18 744 0.6× 503 0.7× 232 0.5× 119 0.3× 781 2.1× 36 1.9k
Nora Horick United States 34 2.0k 1.7× 831 1.2× 706 1.5× 817 2.1× 690 1.9× 188 3.9k
Adriana López United States 21 711 0.6× 511 0.7× 278 0.6× 409 1.1× 581 1.6× 45 2.5k
Alicia K. Morgans United States 29 1.1k 0.9× 429 0.6× 1.9k 4.0× 545 1.4× 557 1.5× 202 3.4k
Chikako Shimizu Japan 30 2.1k 1.8× 689 1.0× 837 1.8× 255 0.7× 1.0k 2.8× 180 3.7k
Brendan Doyle Ireland 23 1.1k 0.9× 550 0.8× 638 1.4× 649 1.7× 1.5k 4.0× 56 3.5k
G.H. Blijham Netherlands 35 2.3k 2.0× 738 1.1× 1.2k 2.5× 1.0k 2.7× 1.1k 2.9× 88 4.6k

Countries citing papers authored by Helle Pappot

Since Specialization
Citations

This map shows the geographic impact of Helle Pappot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helle Pappot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helle Pappot more than expected).

Fields of papers citing papers by Helle Pappot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helle Pappot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helle Pappot. The network helps show where Helle Pappot may publish in the future.

Co-authorship network of co-authors of Helle Pappot

This figure shows the co-authorship network connecting the top 25 collaborators of Helle Pappot. A scholar is included among the top collaborators of Helle Pappot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helle Pappot. Helle Pappot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Christensen, Peter, et al.. (2025). Long-term effect of treatment for non-muscle invasive bladder cancer on Quality of life: a cross-sectional study. Scandinavian Journal of Urology. 60. 141–147.
2.
Missel, Malene, Linda Kahr Andersen, Helle Pappot, et al.. (2025). Understanding symptoms in the lives of adult patients with acute or chronic illness: a phenomenological study of patient experiences. International Journal of Qualitative Studies on Health and Well-Being. 20(1). 2534871–2534871. 1 indexed citations
3.
Dieperink, Karin Brochstedt, et al.. (2025). Patient and Caregiver Education to Support Self‐Efficacy and Self‐Management During Immunotherapy—An Integrative Review. Psycho-Oncology. 34(3). e70100–e70100. 1 indexed citations
5.
Jensen, Jørgen Bjerggaard, Karin Birkenkamp‐Demtröder, Iver Nordentoft, et al.. (2024). 1960O Identification of bladder cancer patients that could benefit from early post-cystectomy immunotherapy based on serial circulating tumour DNA (ctDNA) testing: Preliminary results from the TOMBOLA trial. Annals of Oncology. 35. S1133–S1133. 15 indexed citations
6.
Beisland, Elisabeth Grov, Christian Beisland, Helle Pappot, et al.. (2024). Health-related Quality of Life Assessment in Renal Cell Cancer: A Scoping Review. European Urology Oncology. 8(1). 201–212. 1 indexed citations
7.
Schougaard, Liv Marit Valen, Regine Grytnes, Birgith Engelst Grove, et al.. (2023). Exploring the Nurses' Perspective on Using Remote Electronic Symptom Monitoring in Clinical Decision-Making Among Patients With Metastatic Lung Cancer. Seminars in Oncology Nursing. 39(6). 151517–151517. 3 indexed citations
8.
Kristensen, Claus Andrup, et al.. (2023). Feasibility of Using Wearables for Home Monitoring during Radiotherapy for Head and Neck Cancer—Results from the OncoWatch 1.0 Study. Cancers. 15(2). 422–422. 5 indexed citations
9.
Løppenthin, Katrine, Pernille Envold Bidstrup, Elisabeth Wreford Andersen, et al.. (2023). Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005–2017. Acta Oncologica. 62(12). 1653–1660. 3 indexed citations
11.
Piil, Karin, et al.. (2023). The development of medical infographics to raise symptom awareness and promote communication to patients with cancer: A co-creation study. SHILAP Revista de lepidopterología. 2. 100146–100146. 4 indexed citations
12.
Dióssy, Miklós, Zsófia Sztupinszki, Viktória Tisza, et al.. (2021). Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer. Clinical Cancer Research. 27(13). 3734–3743. 18 indexed citations
14.
Taarnhøj, Gry Assam, et al.. (2021). Patient reported outcomes interfering with daily activities in prostate cancer patients receiving antineoplastic treatment. Acta Oncologica. 60(4). 419–425. 5 indexed citations
16.
Pappot, Helle, Sandrine Aspeslagh, Anne Rogiers, et al.. (2021). Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study. European Journal of Cancer. 157. 225–237. 16 indexed citations
17.
Pappot, Helle, et al.. (2020). The Use of Wearables in Clinical Trials During Cancer Treatment: Systematic Review. JMIR mhealth and uhealth. 8(11). e22006–e22006. 66 indexed citations
18.
Hjøllund, Niels Henrik, et al.. (2020). Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer. Clinical Lung Cancer. 22(2). e169–e179. 15 indexed citations
19.
Hjøllund, Niels Henrik, et al.. (2020). Electronic symptom monitoring in patients with metastatic lung cancer: a feasibility study. BMJ Open. 10(6). e035673–e035673. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026